ABT

An HIV ‘Cure’? Let’s Not Overstate the Success

Merck, J&J and others won't be dropping their research to recreate the success seen in the early treatment of an HIV-positive child. More

Newborn Cured of HIV

A little girl in Mississippi, who was born infected with HIV, was apparently cured of the disease after receiving a three drug cocktail shortly after birth. More

Bausch & Lomb Prepping to Go Public?

A report says private equity investor Warburg Pincus is interviewing investment banks about a potential Bausch & Lomb IPO. More

The Core Portfolio Options Play

Buy-writes on solid companies can replace the income stream that bonds no longer provide. Here are a few ideas. More

Sector Scan: Hospital Supply

Healthcare stocks are booming. Find out which ones are liquid and volatile enough to make a trade or options play worthwhile. More

9 Medical Devices Stocks to Buy Now

The grades of nine Medical Devices stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More

3 Healthcare Stocks About to Receive a Booster Shot

Despite the impressive performance of healthcare stocks as a whole, many aren't getting much analyst love. But these three will -- and when they do, look out! More